River Pharma Italy was founded in 2007 in the province of Milan with the aim of developing Nutraceutical Formulations and Medical Devices consistent with the basic principles of the Pharmaceutical Product: Safety, Quality and Effectiveness.
Area of Focus
Osteoarticular Area Medical Device
By replacing traditional energy sources, wind power significantly cuts greenhouse gas emissions, helping to slow down global warming and protect ecosystems.
Cutting greenhouse gases and combating global warming
By replacing traditional energy sources, wind power significantly cuts greenhouse gas emissions, helping to slow down global warming and protect ecosystems.
Lowering CO₂ footprint and tackling climate crisis
By replacing traditional energy sources, wind power significantly cuts greenhouse gas emissions, helping to slow down global warming and protect ecosystems.
Slashing carbon output and battling rising temperatures
By replacing traditional energy sources, wind power significantly cuts greenhouse gas emissions, helping to slow down global warming and protect ecosystems.
Nutraceuticals
State-of-the-art products based on high molecular weight Hyaluronic Acid obtained through bio-fermentation technology and are characterised by their effectiveness proven in five distinct therapeutic areas.
Medical Devices
The latest generation of medical devices based on Hyaluronic Acid with a high molecular weight, 2 mil D, to be injected, effective for the treatment and prevention of osteoarticular pathologies linked to ageing and for the treatment of acute trauma.
Dermocosmetics
Products that contain, Hyaluronic Acids with a careful selection of molecular weight, amongst other things and are characterised by their anti-ageing effectiveness.
